Target intelligence / Profile preview

Connective tissue metabolism

Molecular classification
Other
01

Overview

Connective tissue metabolism refers to the dynamic set of biochemical processes that govern the synthesis, modification, degradation, and overall turnover of components within connective tissues—such as collagen fibers, elastin fibers, proteoglycans, and glycoproteins. These metabolic activities are essential for maintaining structural integrity throughout the body; they also play key roles in wound healing and adaptation to mechanical stress. Contrary to earlier beliefs that stroma was inert structural material, research has shown that cells within connective tissues—including fibroblasts—actively regulate their own microenvironment through autocrine/paracrine signaling involving peptide hormones like angiotensin II and bradykinin[1]. Dysregulation of these metabolic processes can contribute to pathological conditions such as fibrosis or impaired wound healing. However, "connective tissue metabolism" itself does not refer to any one protein or receptor but rather encompasses an array of cellular activities across multiple cell types found in various forms of connective tissues throughout the body[2][7]. No drugs directly interact with "connective tissue metabolism" as it is not a single molecular entity. However, drugs such as angiotensin-converting enzyme inhibitors can modulate aspects of connective tissue metabolism by influencing collagen turnover in certain contexts[1].

Other names
Metabolism of connective tissueConnective tissue turnoverCollagen turnover (context-dependent)Extracellular matrix remodeling (context-dependent)
02

Biological functions

Structural supportRegulation of extracellular matrix compositionCollagen synthesis and degradationHormone regulation (e.g., peptide hormone generation/degradation)Wound healing and repairImmune response mediation
03

Disease associations

Fibrosis (excess collagen deposition)Inflammatory diseases affecting connective tissues (e.g., rheumatoid arthritis)Cardiovascular disease involving cardiac fibrosis/remodelingOsteoporosis and bone disordersOther disorders involving abnormal extracellular matrix turnover

Beyond the preview

Go deeper on Connective tissue metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connective tissue metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call